Trends in acute myocardial infarction prognosis and treatment in Southwestern France between 1985 and 1990 (The MONICA project-Toulouse)
Reference (19)
- et al.
Left ventricular function after myocardial infarction: clinical and angiographic correlations
J Am Coll Cardiol
(1985) - et al.
Effects of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction
Am Heart J
(1984) - et al.
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction
Am Heart J
(1990) - et al.
Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial
J Am Coll Cardiol
(1992) - et al.
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial
J Am Coll Cardiol
(1993) - et al.
Beta blockade during and after myocardial infarction: an overview of the randomized trials
Prog Cardiovasc Dis
(1985) - et al.
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
Lancet
(1988) ACC/AHA guidelines for the early management of patients with acute myocardial infarction
Circulation
(1990)- et al.
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice?
N Engl J Med
(1992)
Cited by (51)
The major element of 1-year prognosis in acute coronary syndromes is severity of initial clinical presentation: Results from the French MONICA registries
2012, Archives of Cardiovascular DiseasesCitation Excerpt :Our work was based on 2006 data from the French MONICA registries, in which information was collected in all cases of ACS occurring in people aged 35–74 years in three areas in North, North-East and South-West France. These exhaustive, population-based registries collected data from the case files of all patients hospitalized for an ACS (multiple sources were cross-checked), but also from all patients who died out-of-hospital from a suspected ACS, in which case the general practitioner or the physician who notified the death was interviewed [1–4]. Out-of-hospital deaths corresponded to patients dying after an out-of-hospital ACS diagnosis (five of the incident events), those dying after symptoms suggestive of an ACS (67 of the incident events), sudden deaths occurring within 24 hours of the index event (422 of the incident events), and other deaths with insufficient data but without any other suspected cause or medical history (30 of the incident events).
Undiagnosed airflow limitation in patients at cardiovascular risk
2011, Archives of Cardiovascular DiseasesCitation Excerpt :The study was approved by the appropriate ethics committee, in accordance with French law (Comité de protection des personnes Sud-Ouest et Outre-Mer II, number 2-08-25) and all participants signed an informed consent form attesting they had received information about the study and agreed to participate. An extensive questionnaire, derived from the questionnaire used in the French MONICA (monitoring trends and determinants in CVD) population surveys [19] carried out in the same region, was administered to each participant by a trained and certified medical staff member. Data concerning socioeconomic status, personal and family medical history (including family history of premature myocardial infarction, i.e. before 55 years for the father or 65 years for the mother), drug intake, cardiovascular risk factors, pulmonary symptoms (cough, sputum, dyspnoea), lifestyle and quality of life were recorded.
Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007
2009, Archives of Cardiovascular DiseasesAccuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects
2007, Journal of Vascular SurgeryCitation Excerpt :All participants attended a standardized examination protocol, including medical history, physical examination, blood hematology and biochemistry analysis, rest electrocardiography, cardiac cycloergometer exercise testing, and imaging by carotid and femoral duplex ultrasound. Self-reported medical history was completed by a systematic confirmation, including the review of all the medical records available in our hospital database, the interview of the patient’s regular physician, and consultation of the local coronary heart disease (CHD) registry belonging to the Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) World Health Organization (WHO) project.8 As a result of this thorough investigation, 241 of the 2977 initially eligible subjects were excluded because of non-self-reported history of coronary artery disease or stroke.